跟聰明錢學投資!分享你的心水潛力股
On Monday Eastern Time, the three major U.S. stock indexes collectively closed lower as investors awaited the Federal Reserve's final monetary policy meeting of the year, scheduled for December 11.
Against this backdrop, ARK Fund, led by Cathie Wood, showed no signs of concern:While continuing to increase its holdings in Chinese stocks such as Baidu and WeRide, the fund further expanded its positions into innovative sectors like genetic technology, while correspondingly reducing its Tesla holdings, thereby concentrating its portfolio around the core theme of 'Chinese assets + hard tech innovation.'

Direction of Increased Holdings: Strong Conviction in Chinese Assets
Cathie Wood’s recent interest in Chinese assets has shifted from 'exploration' to 'aggressive accumulation,' with substantial purchases of Baidu and WeRide shares over just a few days.
Interpretation: This represents one of ARK’s most decisive moves on Chinese stocks in recent times. Baidu's Luobo Kuaipao, as the leading player in China's Robotaxi market, currently trades at historically low valuations. The market believes that before Tesla’s Robotaxi becomes operational, China's market will progress faster in commercialization, and Baidu's AI monetization capabilities are significantly undervalued.
Interpretation: The strong capital interest in WeRide is underpinned by the company's multiple breakthroughs in technology, commercialization, and global expansion. As the only enterprise globally to have obtained autonomous driving licenses in seven countries, including China, the United States, and the UAE, the company has built a full-stack technology platform ranging from L2 to L4, forming a diversified product matrix covering Robotaxi, Robobus, Robovan, Robosweeper, and L2-level combined assisted driving systems. It has cumulatively received strategic support from top-tier institutions worldwide, including Bosch, NVIDIA, Temasek, and Morgan Stanley Investment Management.
The analysis pointed out that, against the backdrop of the Federal Reserve's interest rate cuts opening a valuation recovery window for technology stocks, WeRide is benefiting not only from ARK and other institutions' long-term optimism about the autonomous driving sector but also from the validation of its profitability model through global commercial implementation. With the accelerated large-scale application of L4 autonomous driving technology, its full-scene layout and cross-regional operational advantages will become even more prominent.
In addition to AI,Cathie Wood’s original expertise — genomics and healthcare innovation — has also seen capital inflows in recent days.
Cathie Wood purchased two consecutive days $Arcturus Therapeutics (ARCT.US)$ , a company focused on mRNA drug and vaccine research and development. Such large-scale continuous position building suggests that ARK may have identified potential positive developments in the company's pipeline research or clinical data. Additionally, Cathie Wood continued to increase her holdings in $Tempus AI (TEM.US)$ 、 $GeneDx Holdings (WGS.US)$ 。
Reduction directions: Continued reductions in Tesla, fintech company IBTA, and biotech ADPT.
Cathie Wood has been continuously reducing her holdings in $Tesla (TSLA.US)$ . The market views this as a standard ARK-style operation — mechanically reducing positions at high stock prices to control portfolio allocation ratios and reallocating profits into those stocks that are currently undervalued. This does not indicate bearishness but rather risk management.
Additionally, Cathie Wood reduced her holdings in the fintech company $Ibotta (IBTA.US)$ by over 1,800 shares and significantly sold off biotech $Adaptive Biotechnologies (ADPT.US)$ Nearly 110,000 shares.
Summary
Through the recent operations of 'Cathie Wood,' it can be observed that Chinese assets are regaining attention, especially leading companies with advanced AI technologies and autonomous driving capabilities.

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments (8)
to post a comment
41
32
